
At the Vitrolife Group, we work every day to unlock the full potential of science and technology to reduce the barriers towards building a family. Together we help our customers and their patients to fulfill the dream of having a healthy baby.
Vitrolife Group is a global provider of medical devices and genetic services. Based on science and advanced research capabilities, we develop services and products for personalized genetic information and medical device products. We support our customers by improving their clinical practice for the patient's outcome of fertility treatment.
Help Modernize Our Azure Footprint and Enable Teams to Work Smarter
Are you passionate about automation, infrastructure as code, and helping teams move from manual processes to modern cloudnative practices?
We’re looking for a Infrastructure Specialist to join our Azure platform team.
In this role, you’ll help convert legacy infrastructure into automated, standardized offerings—and you’ll spend focused periods embedded inside product teams, helping them adopt Terraform, CI/CD automation, and platform guardrails.
If you enjoy learning, collaborating, and solving real technical problems that remove friction for engineering teams, this role is for you.
You’ll work alongside Azure engineers to modernize older Azure environments, migrate manual setups to Terraform, and help product teams adopt platform standards. By embedding into teams, you’ll accelerate their transition away from adhoc infrastructure, guiding them toward automated, secure, and repeatable patterns.
Your work will make our Azure landscape cleaner, more governed, and easier for teams to build on.
This role is ideal for someone early in their cloud/platform career who wants:
Please note that this role is based in Valencia or Gothenburg.
Vitrolife Group is an equal opportunity employer. We welcome and encourage applications from people with disabilities.
Applications will be reviewed on an ongoing basis, so please submit your application as soon as possible.
We are currently approximately 1 100 colleagues worldwide, with headquarters in Gothenburg, Sweden. Vitrolife Group's products and services are available in more than 110 countries through our own presence in 30 countries and a network of distributors. Vitrolife Group is a sustainable market leader and aims to be the preferred partner for IVF-clinics by providing superior products and services with the vision of fulfilling the dream of having a baby. The Vitrolife share is listed on Nasdaq Stockholm.

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry.
In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality.
Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.